(1)
Oya Yonal; Fatih Eren; Yusuf Yılmaz; Özlen Atuğ; Hülya Hamzaoğlu Över. No Association Between the Functional Cannabinoid Receptor Type 2 Q63R Variants and Inflammatory Bowel Disease in Turkish Subjects. Turkish Journal of Gastroenterology 2019, 25, 639-643.